Amino acid replacement: H213P. H213P falls in the first RNA-binding domain.
A12278897C
H213P | bru1-PA; H419P | bru1-PB; H213P | bru1-PE; H213P | bru1-PF; H419P | bru1-PG; H182P | bru1-PH; H182P | bru1-PI; H182P | bru1-PJ; H182P | bru1-PK; A254A | bru1-PL
H213P
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
In aretPA/aretWH, aretPA/aretQB, or aretPA/aretZ2286 adult females, oogenesis proceeds normally until stage 4 - meiosis and mitosis of germ cells occurs normally and nurse cells become enlarged an polyploid. But during stage 4, when mitosis of germ cells is over in wild-type, in around 20% of cysts the nurse cells condense their chromosomes and form large mitotic spindles.
Mutants show a oogenic phenotype.
Oogenesis proceeds normally until approximately stage 9, when the egg chambers deteriorate, in hemizygous females. No late stage eggs are formed or laid. aretPA/aretPD females complete oogenesis and lay eggs, some of which hatch into viable larvae. However, the majority of embryos derived from these females have complex cuticle defects involving partial or complete fusion of adjacent segments.
Almost normal numbers of egg chambers that degenerate early.
Homozygous females usually have almost normal numbers of early stages of egg chambers in their ovaries which degenerated before yolk uptake occurs.
bru1PA/bru1Z2286, mr1/mr2 has abnormal mitotic cell cycle | oogenesis stage S2 phenotype
bru1PA/bru1Z2286, mr1/mr2 has abnormal mitotic cell cycle | oogenesis stage S1 phenotype
bru1QB/bru1PA has phenotype, suppressible by Df(3R)M-Kx1
bru1PA is an enhancer of eye phenotype of Scer\GAL4hs.2sev, mblC.UAS
bru1PA/bru1Z2286, mr1/mr2 has germline cell | female | oogenesis stage S1 phenotype
bru1PA/bru1Z2286, mr1/mr2 has germline cell | female | oogenesis stage S2 phenotype